Form D · Biotechnology
Federated Biologics Inc.
Alexandria, C3 · CIK 0002130284
Offering snapshot reported May 13, 2026 · SEC filing
- Reported sold
- $2.46M Offering amount: $4.4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2026 | Initial | $2,455,000 | No comparison | 4 | SEC filing |
| May 8, 2026 | Initial | $5,999,997 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-583880
Source: Form D, filed May 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Lavner | Director |
| George Peppou | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Shop 1, 2 Ralph Street
Alexandria, C3, NSW 2015
Alexandria, C3, NSW 2015